Verition Fund Management
BDSX icon

Verition Fund Management’s Biodesix BDSX Stock Holding History

Verition Fund Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-549
Closed -$14K – 2154
2022
Q3 		$14K Hold
549
– – ﹤0.01% 2837
2022
Q2 		$18K Buy
+549
New +$17.8K ﹤0.01% 2223

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Verition Fund Management's BDSX Position: Q4 2022 in Review

Verition Fund Management sold out of Biodesix (BDSX) in Q4 2022, closing a stake of 549 shares — an estimated $14K sold.

Verition Fund Management first reported a position in BDSX in Q2 2022 and held it in 2 quarters. The position peaked at $18K in Q2 2022. 33 funds tracked by Wall St. Rank hold BDSX as of Q4 2022.

  • Verition Fund Management reported no remaining Biodesix position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 549 Biodesix shares in Q4 2022, an estimated $14K.
  • Verition Fund Management first reported a position in Biodesix in Q2 2022 and held it in 2 quarters.
  • Verition Fund Management's Biodesix position peaked at $18K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held Biodesix as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.